EUVIMEDOpdag EUVIMED
Crossref

Dopaminergic signalling and behavioural alterations by Comt – Dtnbp1 genetic interaction and their clinical relevance

Francesca Managò, Diego Scheggia iD, Maria Pontillo, Maddalena Mereu, Rosa Mastrogiacomo, Gayatri Udayan, Paola Valentini, Maria Cristina Tata iD, Daniel R Weinberger, Cynthia S Weickert, Pier Paolo Pompa, Maria A De Luca and 2 more

British Journal of Pharmacology · 2023-10 · 180 (19) · 2514-2531

DOI: 10.1111/bph.16147 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2023-06-20. Written by Francesca Managò and 13 co-authors. Institution: Genetics of Cognition Laboratory, Neuroscience Area, Istituto Italiano di Tecnologia, Genoa, Italy. Major MEDLINE topics: DiGeorge Syndrome. Cited 3 times so far (Crossref); 74 references. Funded by: Istituto Italiano di Tecnologia, Fondazione Telethon.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Cognitive and motor functions are modulated by dopaminergic signalling, which is shaped by several genetic factors. The biological effects of single genetic variants might differ depending on epistatic interactions that can be functionally multi‐directional and non‐linear. Experimental Approach We performed behavioural and neurochemical assessments in genetically modified mice and behavioural assessments and genetic screening in human patients with 22q11.2 deletion syndrome (22q11.2DS). Key Results Here, we confirm a genetic interaction between the Comt (catechol‐O‐methyltransferase, human orthologue: COMT ) and Dtnbp1 (dystrobrevin binding protein 1, alias dysbindin, human orthologue: DTNBP1 ) genes that modulate cortical and striatal dopaminergic signalling in a manner not predictable by the effects of each single gene. In mice, Comt ‐by‐ Dtnbp1 concomitant reduction leads to a hypoactive mesocortical and a hyperactive mesostriatal dopamine pathway, associated with specific cognitive abnormalities. Like mice, in subjects with the 22q11.2DS (characterized by COMT hemideletion and dopamine alterations), COMT ‐by‐ DTNBP1 concomitant reduction was associated with analogous cognitive disturbances. We then developed an easy and inexpensive colourimetric kit for the genetic screening of common COMT and DTNBP1 functional genetic variants for clinical application. Conclusions and Implications These findings illustrate an epistatic interaction of two dopamine‐related genes and their functional effects, supporting the need to address genetic interaction mechanisms at the base of complex behavioural traits.

Subjects

MeSH terms (MEDLINE)

DiGeorge SyndromeHumansMiceAnimalsCatechol O-MethyltransferaseDopamineGenetic Predisposition to DiseaseClinical RelevancePolymorphism, Single NucleotideDysbindin

Author keywords

cognitiondopamineepistasisschizophrenia

Substances

Catechol O-MethyltransferaseDopamineDtnbp1 protein, mouseDysbindin

Authors and institutions

  • Genetics of Cognition Laboratory, Neuroscience Area, Istituto Italiano di Tecnologia, Genoa, Italy.
  • Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Department of Neuroscience, Bambino Gesù Children's Hospital, Rome, Italy.
  • Nanobiointeractions and Nanodiagnostics, Istituto Italiano di Tecnologia, Genoa, Italy.
  • Department of Engineering for Innovation, University of Salento, Lecce, Italy.
  • Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, Maryland, USA.

ORCID profiles: Diego Scheggia, Maria Cristina Tata, Francesco Papaleo

Funding

  • Istituto Italiano di Tecnologia
  • Fondazione Telethon

Cite

APA

Managò, F., Scheggia, D., Pontillo, M., Mereu, M., Mastrogiacomo, R., Udayan, G., Valentini, P., Tata, M. C., Weinberger, D. R., Weickert, C. S., Pompa, P. P., De Luca, M. A., Vicari, S., & Papaleo, F. (2023). Dopaminergic signalling and behavioural alterations by Comt – Dtnbp1 genetic interaction and their clinical relevance. British Journal of Pharmacology, 180(19), 2514-2531. https://doi.org/10.1111/bph.16147

Vancouver

Managò F, Scheggia D, Pontillo M, Mereu M, Mastrogiacomo R, Udayan G, et al. Dopaminergic signalling and behavioural alterations by Comt – Dtnbp1 genetic interaction and their clinical relevance. British Journal of Pharmacology. 2023;180(19):2514-2531. doi:10.1111/bph.16147

BibTeX
@article{Manag2023,
  author = {Managò, Francesca and Scheggia, Diego and Pontillo, Maria and Mereu, Maddalena and Mastrogiacomo, Rosa and Udayan, Gayatri and Valentini, Paola and Tata, Maria Cristina and Weinberger, Daniel R and Weickert, Cynthia S and Pompa, Pier Paolo and De Luca, Maria A and Vicari, Stefano and Papaleo, Francesco},
  title = {Dopaminergic signalling and behavioural alterations by Comt – Dtnbp1 genetic interaction and their clinical relevance},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {19},
  pages = {2514--2531},
  doi = {10.1111/bph.16147}
}
Start for free →